share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4：持股變動聲明
SEC announcement ·  04/02 01:36
牛牛AI助理已提取核心訊息
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
輝瑞公司 [PFE] 的舉報人詹姆斯·史密斯於2024年3月28日執行了一項涉及輝瑞股票的交易。公告中未披露該交易的具體細節，包括行動類型、狀態、所涉股票數量、股票性質、交易價格和股票總價值。也沒有提供史密斯在交易後持有的股票數量。
輝瑞公司 [PFE] 的舉報人詹姆斯·史密斯於2024年3月28日執行了一項涉及輝瑞股票的交易。公告中未披露該交易的具體細節，包括行動類型、狀態、所涉股票數量、股票性質、交易價格和股票總價值。也沒有提供史密斯在交易後持有的股票數量。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。